Skip to main content

Table 1 Key sample characteristicsa (N = 1130)

From: Hospital discharge documentation of a designated clinician for follow-up care and 30-day outcomes in hip fracture and stroke patients discharged to sub-acute care

Characteristic Overall (N = 1130) Discharge communication elements present specifying clinician/clinic for follow-up in hospital discharge summary
Designation present (n = 932) Designation omitted (n = 198) P-value
Patient sociodemographic characteristics
 Average age in years at discharge (standard deviation) 80.84 (9.37) 80.64 (9.64) 81.77 (7.97) 0.122
   < 65 years 53 49 (5.26) 4 (2.02) 0.28
  65–69 years 75 66 (7.08) 9 (4.55)  
  70–74 years 112 90 (9.66) 22 (11.11)  
  75–79 years 184 153 (16.42) 31 (15.66)  
  80–84 years 260 211 (22.64) 49 (24.75)  
   ≥ 85 years 446 363 (38.95) 83 (41.92)  
 Female 765 640 (68.67) 125 (63.13) 0.130
 Medicaid 119 100 (10.73) 19 (9.60) 0.637
 Race non-caucasian 26 21 (2.25) 5 (2.53) 0.817
Patient prior medical history
 HCCb Score (standard deviation) 1.19 (.25) 1.09 (0.3) 1.06 (0.2) 0.89
 Index hospital length of stay in days (standard deviation) 6.53 (4.34) 6.65 (4.5) 5.94 (3.7) 0.04
  1–4 days 366 291 (25.75) 75 (6.63) 0.155
  5–6 days 238 193 (17.07) 43 (3.8)  
  7–9 days 263 225 (19.91) 38 (3.36)  
   > 10 days 263 223 (19.73) 40 (3.53)  
Primary diagnosis:
 Stroke 394 284 (30.47) 110 (55.56) 0.000
 Hip fracture 736 648 (69.53) 88 (44.44) 0.000
 Mechanical ventilation or gastrostomy tube placement during index hospitalization 37 34 (3.65) 3 (1.52) 0.126
 Elixhauser comorbidity score (standard deviation) 5.6 (7) 5.6 (7.03) 5.9 (7.04) 0.792
Outcomes
 Re-hospitalization within 30 days 148 119 (12.77) 29 (14.65) 0.477
 Death within 30 days 60 47 (5.04) 13 (6.57) 0.385
 30 Day re-hospitalization and/or death (combined outcome) 198 147 (15.77) 46 (20.71) 0.090
  1. aHCC New Enrollee Hierarchical Condition Category Score created using the Centers for Medicare and Medicaid Services Methodology
  2. bElixhauser Score = Validated modification of the Elixhauser Comorbidity Measure [10]